Education
About Us
Working with TipRanks
Follow Us
Richard Waldron Insider Profile
11 Followers
Richard Waldron, EVP & CFO at Sciclone Pharmaceuticals, holds 0.00 shares in Sciclone Pharmaceuticals (Ticker: SCLN), holds 338.52K shares in BioAtla (Ticker: BCAB). Most recently, Richard Waldron ― shares of Sciclone Pharmaceuticals on ― for an estimated value of ―.
Richard Waldron Sciclone Pharmaceuticals (SCLN)EVP & CFO
Sciclone Pharmaceuticals (SCLN)
EVP & CFO
Ranked #15,839 out of 103,606 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+57.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Richard Waldron's holdings
Insider Roles
CFO
Roles that Richard Waldron holds in companies
Most Profitable Insider Trade
The most profitable trade made by Richard Waldron
Richard Waldron's Trading History
Sciclone Pharmaceuticals
―
―
―
$0.00
BioAtla
Sep 02, 2025
CFO
Uninformative Sell
1.07K
$226.47K
List of latest transactions for each holding click on a transaction to see Richard Waldron's performance on stock
You May Also Like
Richard Waldron insider profile FAQ
What is the percentage of profitable transactions made by Richard Waldron?
The percentage of profitable transactions made by Richard Waldron is 100%.
What is the average return per transaction made by Richard Waldron?
The average return per transaction made by Richard Waldron is 57.00%.
What stocks does Richard Waldron hold?
Richard Waldron holds: SCLN, BCAB stocks.
What was Richard Waldron’s latest transaction?
Richard Waldron latest transaction was an Uninformative Buy of ―.
What was Richard Waldron's most profitable transaction?
Richard Waldron’s most profitable transaction was an Informative Sell of BCAB stock on December 7, 2021. The return on the trade was 58.70%.
What is Richard Waldron's role in Sciclone Pharmaceuticals?
Richard Waldron's role in Sciclone Pharmaceuticals is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.